Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluorine F 18 fluorothymidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 43 for your search:
Start Over
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P020907, NCT00236275
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSI3926g, ML20773, NCT00453362
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573917, NCCTG-N057K, N057K, NCT00553150
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
Phase: Phase II, Phase I
Type: Diagnostic
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 9420-04, 2004-033, NCT00624728
A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: Other
Protocol IDs: J08101, CA180123, NCT00882583
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01438, 03-032, NCI-5917, CDR0000304738, MSKCC-03032, 5917, NCT00062374
Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-005393-73, 06159, NCT00568841
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 200801758, 1R21CA130281, NCT00721799
18F-FLT-PET in Breast Cancer (MK-0000-139)
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 35 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0000-139, 2009_692, NCT01015131
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02899, NA_00017885, J08134, 8340, N01CM00070, P30CA006973, NCT00963807
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02012, CDR0000665163, RTOG 0837, U10CA021661, U10CA180868, RTOG-0837-ACRIN-6689, NCT01062425
FLT PET Imaging for Cervical Cancer
Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 200906786, NCT01075412
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma (CC# 10852)
Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10852, NCT01174238
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA191-011, NCT01225172
Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: J0977, NA_00029263, NCT01226979
3'-Deoxy-3'-18F Fluorothymidine PET/CT in Predicting Response To Chemotherapy Before Surgery in Patients With Locally Advanced Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00266, HM11081, CDR0000689109, ACRIN 6688, 8029, N01CM27165, NCT00572728
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 197811, NCI-2011-03037, P30CA016056, NCT01533948
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00245, CDR0000552705, H-2007-0039, CO06902, 7898, P30CA014520, U01CA062491, WCCC-CO-06902, NCT00499135
Phase I, Open Label, Single Center Safety Study of [F-18]FLT
Phase: Phase I
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: D0008186, NCT00553748
Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC0622, 06-003532, MAYO-MC0622, NCT00575393
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI21897, NCT00694096
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
Phase: Phase I
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI20112, NCT00707343
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08905, NCT00859118
FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib
Phase: Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0658, NCT01143779
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00764, CDR0000688559, WCCC-CO-09904, 8477, CO 09904, P30CA014520, U01CA070095, U01CA062491, NCT01243359
Start Over